Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-27 @ 11:33 PM
Study NCT ID:
NCT06823960
Status:
RECRUITING
Last Update Posted:
2025-02-12
First Post:
2025-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-09
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-02-03
First Submit QC Date:
None
Study First Post Date:
2025-02-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-11
Last Update Post Date:
2025-02-12
Last Update Post Date Type:
ACTUAL